Your browser doesn't support javascript.
loading
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.
Mahmood, Umair; Bang, Andrew; Chen, Yu-Hui; Mak, Raymond H; Lorch, Jochen H; Hanna, Glenn J; Nishino, Mizuki; Manuszak, Claire; Thrash, Emily M; Severgnini, Mariano; Sanborn, Matthew; Sridharan, Vishwajith; Margalit, Danielle N; Tishler, Roy B; Busse, Paul M; Willers, Henning; Mamon, Harvey J; Yoo, Hyung-Jin; Pai, Sara I; Wirth, Lori J; Haddad, Robert I; Chau, Nicole G; Schoenfeld, Jonathan D.
Afiliação
  • Mahmood U; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bang A; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chen YH; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mak RH; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lorch JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nishino M; Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Manuszak C; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Thrash EM; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Severgnini M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sanborn M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sridharan V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Margalit DN; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tishler RB; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Busse PM; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Mamon HJ; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yoo HJ; Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Massachusetts.
  • Pai SI; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
  • Wirth LJ; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chau NG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Schoenfeld JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: jonathan_schoenfeld@dfci.harvard.edu.
Int J Radiat Oncol Biol Phys ; 109(1): 134-144, 2021 01 01.
Article em En | MEDLINE | ID: mdl-32781104
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adenoide Cístico / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adenoide Cístico / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2021 Tipo de documento: Article